Corrigendum to “Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism” [Addiction Neuroscience, Volume 11, June 2024, 100155]

• Madigan L. Bedard,
• Xi-Ping Huang,
• Jackson G. Murray,
• Alexandra C. Nowlan,
• Sara Y. Conley,
• Sarah E. Mott,
• Samuel J. Loyack,
• Calista A. Cline,
• Caroline G. Clodfelter,
• Nabarun Dasgupta,
• Brian Krumm,
• Bryan L. Roth,
• Zoe A. McElligott

Affiliations

Madigan L. Bedard

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Xi-Ping Huang

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; National Institute of Mental Health Psychoactive Drug Screening Program, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Jackson G. Murray

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Alexandra C. Nowlan

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Sara Y. Conley

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Program in Neuroscience, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Sarah E. Mott

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Samuel J. Loyack

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Calista A. Cline

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Caroline G. Clodfelter

Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Nabarun Dasgupta

Injury Prevention Research Center, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Brian Krumm

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA

Bryan L. Roth

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; National Institute of Mental Health Psychoactive Drug Screening Program, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Division of Chemical Biology and Medicinal Chemistry, University of North Carolina at Chapel Hill Eshelman School of Pharmacy, Chapel Hill, 27599, USA

Zoe A. McElligott

Department of Pharmacology, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Bowles Center for Alcohol Studies, The University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, 27599, USA; Corresponding author.